Cargando…
PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431605/ http://dx.doi.org/10.1097/01.HS9.0000851272.68157.fc |
_version_ | 1784780101051744256 |
---|---|
author | Belada, D. Kopeckova, K. Bergua Burgues, J. M. Stevens, D. Nowakowski, G. S. Waldron-Lynch, M. Hadar, N. Weirather, J. Lässig, C. Blair, D. Dreyling, M. |
author_facet | Belada, D. Kopeckova, K. Bergua Burgues, J. M. Stevens, D. Nowakowski, G. S. Waldron-Lynch, M. Hadar, N. Weirather, J. Lässig, C. Blair, D. Dreyling, M. |
author_sort | Belada, D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94316052022-08-31 PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA Belada, D. Kopeckova, K. Bergua Burgues, J. M. Stevens, D. Nowakowski, G. S. Waldron-Lynch, M. Hadar, N. Weirather, J. Lässig, C. Blair, D. Dreyling, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431605/ http://dx.doi.org/10.1097/01.HS9.0000851272.68157.fc Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Belada, D. Kopeckova, K. Bergua Burgues, J. M. Stevens, D. Nowakowski, G. S. Waldron-Lynch, M. Hadar, N. Weirather, J. Lässig, C. Blair, D. Dreyling, M. PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA |
title | PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA |
title_full | PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA |
title_fullStr | PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA |
title_full_unstemmed | PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA |
title_short | PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA |
title_sort | pb2110: pharmacokinetics and pharmacodynamics in first-mind: a phase ib, open-label, randomized study of tafasitamab ± lenalidomide + r-chop in patients with newly diagnosed diffuse large b-cell lymphoma |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431605/ http://dx.doi.org/10.1097/01.HS9.0000851272.68157.fc |
work_keys_str_mv | AT beladad pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT kopeckovak pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT berguaburguesjm pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT stevensd pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT nowakowskigs pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT waldronlynchm pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT hadarn pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT weiratherj pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT lassigc pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT blaird pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma AT dreylingm pb2110pharmacokineticsandpharmacodynamicsinfirstmindaphaseibopenlabelrandomizedstudyoftafasitamablenalidomiderchopinpatientswithnewlydiagnoseddiffuselargebcelllymphoma |